Participants With Extensive Stage Small Cell Lung Cancer clinical trials

Explore recruiting participants with extensive stage small cell lung cancer clinical trials.

Recruiting participants with extensive stage small cell lung cancer studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Participants With Extensive Stage Small Cell Lung Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 1b/2 Study to Evaluate the Efficacy and Safety of Investigational Agents as Monotherapy or in Combination With Pembrolizumab for the Treatment of Participants With PD-1/L1-refractory Extensive-Stage Small Cell Lung Cancer in Need of Second-Line Therapy (KEYNOTE-B98)

Spain, Hungary, Poland, Austria, Italy

Phase I and Phase II (Integrated)- Other EU CTIS Study details

C6461004 - A GLOBAL PHASE 2/3 INTERVENTIONAL STUDY OF PF-08634404 IN COMBINATION WITH CHEMOTHERAPY IN PARTICIPANTS WITH EXTENSIVE-STAGE SMALL CELL LUNG CANCER

France, Italy, Germany, Spain

Phase II and Phase III (Integrated) EU CTIS Study details

A Phase 2 Study to Evaluate the Efficacy and Safety of Pembrolizumab plus Investigational Agents in Combination with Etoposide and Cisplatin or Carboplatin for the First-Line Treatment of Participants with Extensive-Stage Small Cell Lung Cancer (KEYNOTE-B99)

Poland, Hungary, Spain, Italy, Austria

Therapeutic exploratory (Phase II) EU CTIS Study details

A Randomized, Double-Blind, Multicenter Phase 3 Trial of BMS-986489 (BMS-986012 + Nivolumab Fixed Dose Combination) in Combination with Carboplatin plus Etoposide vs Atezolizumab in Combination with Carboplatin plus Etoposide as First-line Therapy in Extensive-Stage Small Cell Lung Cancer

France, Romania, Netherlands, Greece, Spain, Austria +5 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase III, Randomized, Open-Label, Multicenter Study of Lurbinectedin in Combination with Atezolizumab Compared with Atezolizumab as Maintenance Therapy in Participants with Extensive-Stage Small-Cell Lung Cancer (ES-SCLC) Following First-Line Induction Therapy with Carboplatin, Etoposide and Atezolizumab

Italy, Belgium, Hungary, Germany, Spain, Greece +1 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 3, Randomized, Double-Blind Study of MK-7684A in Combination with Etoposide and Platinum Followed by MK-7684A vs Atezolizumab in Combination with Etoposide and Platinum Followed by Atezolizumab for the First-Line Treatment of Participants with Extensive-Stage Small Cell Lung Cancer (KEYVIBE-008)

Netherlands, Spain, Hungary, Finland, Romania, Italy +8 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Participants With Extensive Stage Small Cell Lung Cancer trials by city

Participants With Extensive Stage Small Cell Lung Cancer in Toronto Participants With Extensive Stage Small Cell Lung Cancer in Vancouver Participants With Extensive Stage Small Cell Lung Cancer in Montreal Participants With Extensive Stage Small Cell Lung Cancer in Calgary Participants With Extensive Stage Small Cell Lung Cancer in Edmonton Participants With Extensive Stage Small Cell Lung Cancer in Ottawa Participants With Extensive Stage Small Cell Lung Cancer in Winnipeg Participants With Extensive Stage Small Cell Lung Cancer in Quebec City Participants With Extensive Stage Small Cell Lung Cancer in Hamilton Participants With Extensive Stage Small Cell Lung Cancer in Kitchener Participants With Extensive Stage Small Cell Lung Cancer in London Participants With Extensive Stage Small Cell Lung Cancer in Halifax Participants With Extensive Stage Small Cell Lung Cancer in New York Participants With Extensive Stage Small Cell Lung Cancer in Los Angeles Participants With Extensive Stage Small Cell Lung Cancer in Chicago Participants With Extensive Stage Small Cell Lung Cancer in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease